Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Speed of Onset of Fixed Dose IV Hydromorphone for Acute Severe Pain in ED
NCT00305110Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2006
- Primary completion
- Oct 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydromorphone in acute pain, sponsored by Montefiore Medical Center. Primary endpoint: Number of Participants Requiring Naloxone. Started Jan 2006; status: completed.
02
Drugs
hydromorphone
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00305110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305110.